This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Inovio Pharmaceuticals

An under-$10 stock in the biotechnology and drugs complex that looks ready to trigger a breakout trade is Inovio Pharmaceuticals (INO - Get Report), which is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. This stock is off to a strong start in 2012, with shares up sharply by 48%.

>>4 Health Care Stocks Under $10 Spiking Higher

If you take a look at the chart for Inovio Pharmaceuticals, you'll notice that this stock has been uptrending very strong for the past six months, with shares soaring from 38 cents to a recent high of 76 cents per share. During that uptrend, shares of INO have been mostly making higher lows and higher highs, which is bullish technical price action. That trend has now pushed shares of INO within range of triggering a major breakout trade.

Traders should now look for long-biased trades in INO once it manages to break out above some near-term overhead resistance at 76 cents per share with high volume. Look for a sustained move or close above 76 cents with volume that hits near or above its three-month average volume of 553,362 shares. If that breakout triggers soon, then INO will setup to re-test or possibly take out its next major overhead resistance levels at 89 to 96 cents per share, and possibly even $1.20 to $1.30 a share or higher.

Traders can look to buy INO as long as it's trending above its 50-day moving average of 60 cents per share with strong upside volume flows. I would add to any long positions once INO manages to take out 76 cents per share with heavy volume, and then add again above 89 to 96 cents per share.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
LPR $0.09 0.00%
CPRX $0.61 -0.60%
GURE $1.45 -5.23%
INO $9.08 -3.30%
SVU $4.61 -0.65%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs